Michael Durkin MD MPH

Healthcare Associated Infections

Physician

620 S Taylor Ave# DvSt. Louis, MO 63110
Phone+1 314-362-9098
Fax+1 314-362-9851

Dr. Durkin is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Durkin's full profile Already have an account?

Summary

Dr. Michael Durkin is an Infectious Disease specialist based in St. Louis, MO, with a focus on healthcare-associated infections. He completed his residency in Internal Medicine at Washington University/B-JH/SLCH Consortium, followed by a fellowship in Infectious Disease at Duke University Hospital. He also holds an MPH in Epidemiology from the University of North Carolina. Dr. Durkin serves as the Section Chief of Infectious Diseases at the VA St. Louis Health Care System and holds multiple academic positions at Washington University and Barnes-Jewish Hospital. He has extensive experience in general infectious disease, public health, opioid-related disorders, epidemiology, and infection control. His recent publications cover various topics, including opioid use disorder treatment, hepatitis C virus treatment, and antibiotic stewardship. Dr. Durkin has been involved in clinical trials related to shared decision-making, mobile health, and antibiotic efficacy. He was recognized as a Fellow by the Society for Healthcare Epidemiology of America and the Infectious Diseases Society of America.

Education & Training

University of North CarolinaMPH, Epidemiology, 2013 - 2015
Duke University HospitalFellowship, Infectious Disease, 2012 - 2015
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2008 - 2011
Medical College of WisconsinClass of 2008

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MO State Medical License 2011 - 2027
NC State Medical License 2012 - 2016
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

President ID Society of St. Louis Infectious Diseases Society of America Affiliate, 2025-2026
Fellow Society for Healthcare Epidemiology of America, 2022
Fellow Infectious Diseases Society of America, 2021

Clinical Trials

CTTI Risk Factors for HABP/VABP Study
COMPLETED
Nutraceutical Efficacy for rUTI Start of enrollment: 2018 Mar 22
TERMINATED
PHASE2, PHASE3
Stigma and a Shared Decision Aid Start of enrollment: 2022 Apr 07
COMPLETED
NA

Publications & Presentations

PubMed

Real-World Experience of Hepatitis C Treatment With Glecaprevir-Pibrentasvir During Pregnancy.
L Madeline McCrary, Megan R Curtis, Jeannie C Kelly, Jessica Elrod-Gallegos, Patrick Kojima
Clinical Infectious Diseases. 2026-08-11
Patterns of Antibiotic Utilization and Bacterial Susceptibility of Prenatal Urinary Tract Infections.
Paige D Wartko, Sharon Fuller, Lisa Bastarache, Susan M Shortreed, Katelin B Nickel
Journal of Women's Health. 2026-06-29
Amoxicillin-Clavulanate vs Amoxicillin for Acute Sinusitis in Adults.
Timothy J Savage, Anne M Butler, Matthew P Kronman, Michael J Durkin, Sushama Kattinakere Sreedhara
JAMA. 2026-05-19

Journal Articles

Addiction Medicine Consultations Reduce Readmission Rates for Patients with Serious Infections from Opioid Use Disorder
David K Warren, Michael J Durkin, Evan S Schwarz, Clinical Infectious Diseases

Books/Book Chapters

Burket's Oral Medicine
Chapter: Infectious Diseases
Page 785 - 816Michael Durkin, Noha Seoudi, Raj NairEditors: Michael Glick, Martin Greenberg, Peter Lockhart, Stephen Challacombe.Wiley, Hoboken, NJEdition 13,2021
The Washington Manual Infectious Diseases Subspecialty Consult Book
Chapter: Approach to the Infectious Disease Consultation
Page 1 - 8Liang SY, Durkin MJ, Kirmani N.Editors: Nigar Kirmani, Michael J. Durkin, Stephen Y. Liang.Wolters Kluwer, PhiladelphiaEdition 3rd,2020
Washington Manual Infectious Diseases Subspecialty Consult
Chapter: Fever of Unknown Origin
Page 31 - 40Saeed MJ, Durkin MJEditors: Nigar Kirmani, Michael J. Durkin, Stephen Y. Liang.Wolters Kluwer, PhiladelphiaEdition 3rd,2020

Press Mentions

Leadership Announcement – New John Cochran VA Section ChiefsApril 9th, 2025
IDSA Honors 199 Distinguished Clinicians, Scientists with FIDSA DesignationNovember 16th, 2021
Halting Opioid Abuse Aim of Several Grants from NIH, CDCDecember 3rd, 2019

Grant Support

Developmental Center for AIDS Research Grant - Scientific Working GroupNIH(NIAID) - Co-I on D-CFAR and Co-PI of Scientific Working Group2024–2029
Informatics Approaches to Understand and Reduce Inappropriate Antibiotic Prescribing by DentistsNIH(NIDCR)2023–2028
Comparative Risk of Oral Complications Associated with Medications for Opioid Use Disorder: A Mixed-Methods ApproachNIH (NIDCR)2023–2028
Identifying Optimal Antibiotic Regimens to Treat Urinary Tract Infections During PregnancyNIH(NICHD)2022–2027
Washington University & BJC Epicenter to Prevent Healthcare Associated Infections & Antibiotic ResistanceCDC2021–2026